Joint Offering Supports Efficient Clinical Decision-Making for Patients
Milwaukee, WI & Irvine, CA -- February 23, 2012 -- GE Healthcare and Masimo (NASDAQ: MASI) jointly announced a long-term agreement under which GE will incorporate Masimo rainbow® SET technology into many of GE Healthcare's patient monitoring products.
Chalfont St Giles, UK -- 20 February 2012 -- GE Healthcare, the healthcare business of GE (NYSE: GE) announced today that it is to begin offering Fast Trak training in a state-of-the-art facility at the School of Life Sciences and Chemical Technology, Ngee Ann Polytechnic, Singapore.
Chalfont St Giles, UK -- 2 February 2012 -- GE Healthcare Life Sciences today announced the winners of 2011 IN Cell Analyzer Image Competition. Geoffrey Grandjean from the United States, Marie Neguembor from Italy, and Lesley Caron from Australia, each took first place in a regional category. The winning images will be displayed on NBC Universal's high-definition screen in Times Square, New York at a special event held April 20-22 2012.
GE Healthcare's Discovery NM 750b is a specialized breast scanner that enables advanced functional imaging of breast cancer
Hopewell Township, NJ and Waukesha, WI January 30, 2011 ---Capital Health and GE Healthcare announced today the first Discovery* NM 750b was installed at Capital Health's New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine, with significant investments in advanced technologies and its medical staff.
Bionime will offer innovative GE-branded clinical and home-based patient care products for the rapidly growing global diabetes population
Albany, NY and Milwaukee, WI --17 January 2012-- GE (NYSE: GE) today announced it has entered into a new worldwide licensing agreement with Bionime, a global leader in biotechnology medical testing, to provide new GE-branded solutions for the diabetes market.
